Aurora Spine Corporation ASG.V
Health Care · Health Care Equipment & Services · TSX-V · Canada · aurora-spine.com
Aurora Spine Corporation develops and distributes minimally invasive spinal implants and fusion devices for the treatment of degenerative disc disease and spinal conditions. The company's product portfolio includes interspinous process lumbar fusion systems (ZIP series), titanium-coated interbody cages, and DEXA Technology-based implants for lumbar and cervical procedures. It trades on the TSXV and OTCQB markets.
Key ratios
FreeCashFlowOnSale TTM 0.01
FreeCashFlowOnSale 2024 0.03
FreeCashFlowOnSale 2023 -0.1
FreeCashFlowOnSale 2022 -0.16
NetIncomeMargin TTM -0.07
NetIncomeMargin 2024 -0.06
NetIncomeMargin 2023 -0.12
NetIncomeMargin 2022 -0.1
ReturnOnAssets TTM -0.05
ReturnOnAssets 2024 -0.04
ReturnOnAssets 2023 -0.08
ReturnOnAssets 2022 -0.08
ReturnOnEquity TTM -0.3
ReturnOnEquity 2024 -0.21
ReturnOnEquity 2023 -0.35
ReturnOnEquity 2022 -0.3
Recent news
Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide
2026-07-16 · Newsfile
Aurora Spine Corporation Announces First Quarter FY26 Financial Results
2026-05-28 · GlobeNewswire
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
2026-05-07 · BioSpace
Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results
2026-04-30 · GlobeNewswire
Aurora Spine Announces Issuance of Two U.S. Patents
2026-01-08 · GlobeNewswire